Singapore markets closed
  • Straits Times Index

    3,230.55
    +21.37 (+0.67%)
     
  • Nikkei

    26,781.68
    +176.84 (+0.66%)
     
  • Hang Seng

    20,697.36
    +581.16 (+2.89%)
     
  • FTSE 100

    7,585.46
    +20.54 (+0.27%)
     
  • BTC-USD

    28,797.09
    -267.43 (-0.92%)
     
  • CMC Crypto 200

    625.79
    -3.71 (-0.59%)
     
  • S&P 500

    4,158.24
    +100.40 (+2.47%)
     
  • Dow

    33,212.96
    +575.77 (+1.76%)
     
  • Nasdaq

    12,131.13
    +390.48 (+3.33%)
     
  • Gold

    1,857.30
    +3.40 (+0.18%)
     
  • Crude Oil

    115.07
    +0.98 (+0.86%)
     
  • 10-Yr Bond

    2.7430
    -0.0130 (-0.47%)
     
  • FTSE Bursa Malaysia

    1,546.76
    +5.61 (+0.36%)
     
  • Jakarta Composite Index

    7,026.26
    +142.75 (+2.07%)
     
  • PSE Index

    6,726.14
    +80.62 (+1.21%)
     

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exicure, Inc. (XCUR)

  • Oops!
    Something went wrong.
    Please try again later.
·3-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

BENSALEM, Pa., December 20, 2021--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming February 11, 2022 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Exicure, Inc. ("Exicure" or the "Company") (NASDAQ: XCUR) securities between March 11, 2021 and November 15, 2021, inclusive (the "Class Period").

Investors suffering losses on their Exicure investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

On November 15, 2021, after the market closed, Exicure filed a Form 12b-25 with the SEC stating that it could not timely file its quarterly report for the period ended September 30, 2021. It explained that the Company was investigating "a claim made by a former Company senior researcher regarding alleged improprieties that researcher claims to have committed with respect to the Company’s XCUR-FXN preclinical program for the treatment of Friedreich’s ataxia."

On this news, the Company’s stock price fell $0.30, or 28%, to close at $1.07 per share on November 16, 2021, on unusually heavy trading volume.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that there had been certain improprieties in Exicure’s preclinical program for the treatment of Friedreich’s ataxia; (2) that, as a result, there was a material risk that data from the preclinical program would not support continued clinical development; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you purchased or otherwise acquired Exicure securities during the Class Period, you may move the Court no later than February 11, 2022 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211220005147/en/

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting